Contact

All Stories

  1. Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial

    Article • Trials, April 2024, Springer Science + Business Media

    Dr Vishal C Patel

  2. Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: Study protocol for a randomised controlled trial

    Article • December 2023, Cold Spring Harbor Laboratory Press

    Dr Vishal C Patel

  3. Von Willebrand factor as a predictor of mortality in acute‐on‐chronic liver failure: Do not throw out the baby with the bathwater

    Article • Liver International, December 2023, Wiley

    Dr Vishal C Patel

  4. Von Willebrand factor is an independent predictor of short‐term mortality in acutely ill patients with cirrhosis

    Article • Liver International, September 2023, Wiley

    Dr Vishal C Patel

  5. Lysophosphatidylcholines modulate immunoregulatory checkpoints in peripheral monocytes and are associated with mortality in people with acute liver failure

    Article • Journal of Hepatology, March 2023, Elsevier

    Dr Vishal C Patel

  6. Carvedilol in patients with compensated cirrhosis: the ongoing benefits of definitive randomised trials over meta-analysis in patients with small varices

    Article • Journal of Hepatology, December 2022, Elsevier

    Dr Vishal C Patel

  7. General practitioner perspectives on factors that influence implementation of secondary care-initiated treatment in primary care: Exploring implementation beyond the context of a clinical trial

    Article • PLoS ONE, October 2022, PLOS

    Dr Vishal C Patel

  8. Using a theory-informed approach to explore patient and staff perspectives on factors that influence clinical trial recruitment for patients with cirrhosis and small oesophageal varices

    Article • PLoS ONE, February 2022, PLOS

    Dr Vishal C Patel

  9. Fibrin clot quality in acutely ill cirrhosis patients: Relation with outcome and improvement with coagulation factor concentrates

    Article • Liver International, December 2021, Wiley

    Dr Vishal C Patel

  10. Prevalence of Bleeding and Thrombosis in Critically Ill Patients with Chronic Liver Disease

    Article • Thrombosis and Haemostasis, October 2021, Thieme Publishing Group

    Dr Vishal C Patel

  11. Aberrant hepatic trafficking of gut‐derived T‐cells is not specific to primary sclerosing cholangitis

    Article • Hepatology, October 2021, Wiley

    Dr Vishal C Patel

  12. Rifaximin reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial

    Article • Journal of Hepatology, September 2021, Elsevier

    Dr Vishal C Patel

  13. Dysregulation of the Lysophosphatidylcholine/Autotaxin/Lysophosphatidic Acid Axis in Acute‐on‐Chronic Liver Failure Is Associated With Mortality and Systemic Inflammation by Lysophosphatidic Acid–Dependent Monocyte Activation

    Article • Hepatology, June 2021, Wiley

    Dr Vishal C Patel

  14. Hemostatic balance in acute‐on‐chronic liver failure

    Article • Journal of Thrombosis and Haemostasis, March 2021, Wiley

    Dr Vishal C Patel

  15. P225 Partial splenic artery embolisation for portal hypertension – a single centre experience

    Article • January 2021, BMJ

    Dr Vishal C Patel

  16. Global hemostatic status in patients with acute‐on‐chronic liver failure and septics without underlying liver disease

    Article • Journal of Thrombosis and Haemostasis, November 2020, Wiley

    Dr Vishal C Patel

  17. Modulating the gut–liver axis and the pivotal role of the faecal microbiome in cirrhosis

    Article • Clinical Medicine, September 2020, Royal College of Physicians

    Dr Vishal C Patel

  18. Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis

    Article • JHEP Reports, July 2020, Elsevier

    Dr Vishal C Patel

  19. Whole blood thrombin generation profiles of patients with cirrhosis explored with a near patient assay

    Article • Journal of Thrombosis and Haemostasis, February 2020, Wiley

    Dr Vishal C Patel

  20. Antimicrobial resistance in chronic liver disease

    Article • Hepatology International, December 2019, Springer Science + Business Media

    Dr Vishal C Patel

  21. Mixed Fibrinolytic Phenotypes in Decompensated Cirrhosis and Acute‐on‐Chronic Liver Failure with Hypofibrinolysis in Those With Complications and Poor Survival

    Article • Hepatology, October 2019, Wiley

    Dr Vishal C Patel

  22. Rifaximin reduces the incidence of spontaneous bacterial peritonitis, variceal bleeding and all-cause admissions in patients on the liver transplant waiting list

    Article • Alimentary Pharmacology & Therapeutics, June 2019, Wiley

    Dr Vishal C Patel

  23. PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial

    Article • BMJ Open, February 2019, BMJ

    Dr Vishal C Patel

  24. Therapeutic plasma exchange as a novel treatment for severe intrahepatic cholestasis of pregnancy: Case series and mechanism of action

    Article • Journal of Clinical Apheresis, October 2018, Wiley

    Dr Vishal C Patel

  25. In vitro efficacy of pro- and anticoagulant strategies in compensated and acutely ill patients with cirrhosis

    Article • Liver International, May 2018, Wiley

    Dr Vishal C Patel

  26. Platelet-leucocyte aggregation is augmented in cirrhosis and further increased by platelet transfusion

    Article • Alimentary Pharmacology & Therapeutics, March 2018, Wiley

    Dr Vishal C Patel

  27. Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failure

    Article • Journal of Critical Care, February 2018, Elsevier

    Dr Vishal C Patel

  28. Mucosa-associated invariant T cells link intestinal immunity with antibacterial immune defects in alcoholic liver disease

    Article • Gut, November 2017, BMJ

    Dr Antonio Riva, Dr Vishal C Patel

  29. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease

    Article • Alimentary Pharmacology & Therapeutics, October 2017, Wiley

    Dr Vishal C Patel

  30. CD14+CD15−HLA-DR−myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure

    Article • Gut, June 2017, BMJ

    Dr Vishal C Patel

  31. MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure

    Article • Gut, April 2017, BMJ

    Dr Vishal C Patel

  32. High-Speed Quantitative UPLC-MS Analysis of Multiple Amines in Human Plasma and Serum via Precolumn Derivatization with 6-Aminoquinolyl-N-hydroxysuccinimidyl Carbamate: Application to Acetaminophen-Induced Liver Failure

    Article • Analytical Chemistry, February 2017, American Chemical Society (ACS)

    Dr Vishal C Patel

  33. Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis

    Article • Journal of Hepatology, May 2016, Elsevier

    Dr Vishal C Patel

  34. The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-α

    Article • Liver International, April 2016, Wiley

    Dr Vishal C Patel

  35. Neutrophil Toll-Like Receptor 9 Expression and the Systemic Inflammatory Response in Acetaminophen-Induced Acute Liver Failure

    Article • Critical Care Medicine, January 2016, Wolters Kluwer Health

    Dr Antonio Riva, Dr Vishal C Patel

  36. High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial

    Article • Journal of Hepatology, January 2016, Elsevier

    Dr Vishal C Patel

  37. Altered Gut Microbial Profile is a Proponent of Bacterial Translocation in Acute-on-Chronic Liver Failure

    Article • Journal of Hepatology, January 2016, Elsevier

    Dr Vishal C Patel

  38. Clinical science workshop: targeting the gut-liver-brain axis

    Article • Metabolic Brain Disease, October 2015, Springer Science + Business Media

    Dr Vishal C Patel

  39. Bile Acid Profiling and Quantification in Biofluids Using Ultra-Performance Liquid Chromatography Tandem Mass Spectrometry

    Article • Analytical Chemistry, September 2015, American Chemical Society (ACS)

    Dr Vishal C Patel

  40. Increased Survival for Patients With Cirrhosis and Organ Failure in Liver Intensive Care and Validation of the Chronic Liver Failure–Sequential Organ Failure Scoring System

    Article • Clinical Gastroenterology and Hepatology, July 2015, Elsevier

    Dr Maheeba Abdulla, Dr Vishal C Patel

  41. Immunotherapy in the treatment and prevention of infection in acute-on-chronic liver failure

    Article • Immunotherapy, July 2015, Future Medicine

    Dr Vishal C Patel

  42. Salivary microbiota-immune profiling in cirrhosis: Could this be the noninvasive strategy that will revolutionize prognostication in hepatology?

    Article • Hepatology, June 2015, Wiley

    Dr Vishal C Patel

  43. Patients With Acute-on-Chronic Liver Failure Have Increased Numbers of Regulatory Immune Cells Expressing the Receptor Tyrosine Kinase MERTK

    Article • Gastroenterology, March 2015, Elsevier

    Dr Vishal C Patel

  44. Diabetes and the gastrointestinal tract

    Article • Medicine, May 2011, Elsevier

    Dr Vishal C Patel

  45. Retrospective analysis of the impact of a low glycaemic index diet on hospital stay following coronary artery bypass grafting: a hypothesis

    Article • Journal of Human Nutrition and Dietetics, June 2004, Wiley

    Dr Vishal C Patel